Makoto Naoi
- Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 79
- Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 64
- Neurotransmitter Receptor Influence on Behavior 30
- Nerve injury and regeneration 18
- Biological Psychiatry top 2%
- Biochemistry top 0.5%
- Amino Acid Enzymes and Metabolism 24
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 79
-
- Cholinesterase and Neurodegenerative Diseases 22
-
- Polyamine Metabolism and Applications 18
- Glycosylation and Glycoproteins Research 14
Makoto Naoi
231 papers receiving 7.7k citations
Peers
Comparison fields: 5 of 143
- Neurology 2.7k
- Cellular and Molecular Neuroscience 3.0k
- Biological Psychiatry 238
- Biochemistry 502
- Neurology 557
Countries citing papers authored by Makoto Naoi
This map shows the geographic impact of Makoto Naoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Naoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Naoi more than expected).
Fields of papers citing papers by Makoto Naoi
This network shows the impact of papers produced by Makoto Naoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Naoi. The network helps show where Makoto Naoi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Makoto Naoi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 74 | |
| 2 | 2011 | 27 | |
| 3 | 2009 | 61 | |
| 4 | 2008 | 21 | |
| 5 | 2002 | 51 | |
| 6 | 2002 | 29 | |
| 7 | 2002 | 80 | |
| 8 | 2002 | 25 | |
| 9 | 2001 | 30 | |
| 10 | 2001 | 38 | |
| 11 | 2000 | 29 | |
| 12 | 2000 | 75 | |
| 13 | 1999 | 104 | |
| 14 | 1999 | 117 | |
| 15 | 1998 | 39 | |
| 16 | 1994 | 13 | |
| 17 | Methods in neurotransmitter and neuropeptide research | 1993 | 46 |
| 18 | 1993 | 21 | |
| 19 | 1988 | 17 | |
| 20 | Immobilized D-amino acid oxidase. | 1978 | 13 |
About Makoto Naoi
Makoto Naoi is a scholar working on Cellular and Molecular Neuroscience, Neurology and Biochemistry, having authored 232 papers that have together received 7.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (79 papers), Neuroscience and Neuropharmacology Research (64 papers), Neurotransmitter Receptor Influence on Behavior (30 papers), Amino Acid Enzymes and Metabolism (24 papers), Cholinesterase and Neurodegenerative Diseases (22 papers), Nerve injury and regeneration (18 papers), Polyamine Metabolism and Applications (18 papers) and Glycosylation and Glycoproteins Research (14 papers). The work is most often cited by research in Neurology (2.7k citations), Cellular and Molecular Neuroscience (3.0k citations) and Biological Psychiatry (238 citations). Makoto Naoi has collaborated with scholars based in Japan, Israel and Czechia. Frequent co-authors include Wakako Maruyama, Masayo Shamoto‐Nagai, Tsutomu Takahashi, W. Maruyama, Yukihiro Akao, P. Dostert, Toshiharu Nagatsu, Moussa B. H. Youdim, Hong Yi and Kunio Yagi. Their work appears in journals such as Analytical Chemistry, Neurology and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.